Can Bathing with Chlorhexidine Reduce VAP?
Dr. Weihong Zhang, Director of Infection Management Office, the First Affiliated Hospital of Nanjing Medical University (China), and colleagues conducted a meta-analysis of available data to assess whether daily bathing with CHG results in the reduction of VAP.
"We found that daily bathing with 2% CHG impregnated cloth or wipes decreased VAP risk among critically ill patients (RR: 0.73, 95% CI: 0.57-0.93)," the authors write in a report published in the Journal of Thoracic Disease. "Our findings suggest that daily bathing with CHG could reduce the risk of VAP in ICU settings."
While previous studies have highlighted the benefits of daily CHG baths in preventing nosocomial infections regardless of whether bathing is done using CHG impregnated cloths or a liquid preparation, the authors note that no standard intervention has been established.
The authors searched PubMed, Embase and the Cochrane Central Register databases for all published studies related to the application of daily CHG bathing to reduce VAP risk in critically ill adult patients. Studies were excluded when CHG bathing was not applied as the primary part of intervention. Additional studies were identified by a manual search of references of original studies or review articles on this topic.
If between-study heterogeneity was found, a random effect model was conducted. If I2 was ≤50%, a fixed effects model was used to calculate a pooled estimate of effect; if the I2 statistic was >50%, a random effect model was used. Publication bias was evaluated by the linear regression asymmetry test by Egger et al. All data were analysed in Review Manager (v.5.1.6; Oxford, England) and STATA11.0 (Stata-Corp, College Station, Tex).
Results and Discussion
In all, six articles reporting a total of 27,638 ventilator-days met the inclusion criteria: 132 patients in the CHG arm developed VAP (13,349 ventilator-days), compared with 188 patients in the control arm (14,289 ventilator-days). Daily bathing with CHG was significantly associated with decreased incidence risk of VAP [relative risk (RR): 0.73, 95% confidence interval (CI): 0.57-0.92, I2=0%].
A subgroup analysis showed that daily bathing with 2% CHG impregnated cloths or wipes reduced the incidence risk of VAP among before-and-after studies (pooled RR: 0.73, 95% CI: 0.57-0.93).
Existing data — even if mainly obtained from quasi-experimental studies— support the practice of daily bathing with CHG for reducing VAP for critically ill patients. Additional well-designed large studies are required for the validation of this association. Nevertheless, the crucial impact of daily CHG baths in preventing VAP should not be neglected by infection preventionists and healthcare workers.
Image credit: Wikimedia Commons
Published on : Mon, 25 May 2015
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
The HAMILTON-S1 is one of the most advanced mechanical ventilators with a number of unique features. It was the first ventilator featuring the "Ventilation Autopilot" INTELLiVENT®-ASV®. · Automated control of the patient’s Ventilation
Features Mindray BeneVision Central Monitoring System is a powerful and scalable solution providing for continuous, real-time surveillance across networks large and small. The system can display patient information from networked monitors, wireless...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
The fully featured ICU ventilator, HAMILTON-MR1, guarantees uncompromised continuous ventilation care from the ICU to the MRI scanner and back. Its reliability and high performance, with advanced lung-protective strategies and patient-adaptive modes,...